SEC probes SAC Capital over profits from biotech buyout; Bernstein gives slim odds to Abbott business attracting bids;

@FierceBiotech: Eyetech vets launch Imagen Biotech with $40M A round. Will work on new treatments for dry AMD, other eye diseases. News | Follow @FierceBiotech

@JohnCFierce: Development stage biotech IRX is moving to FL, where it promises to grow from 40 to 280 in 5 yrs. What are the odds? Item | Follow @JohnCFierce

@RyanMFierce: Full BG-12 data from DEFINE this AM, still looks promising, still waiting for CONFIRM results. Report | Follow @RyanMFierce

@MaureenFierce: MIT tech could boost AIDS vaccine work. Story | Follow @MaureenFierce

> SAC Capital Advisors is under investigation as SEC officials seek to determine whether the hedge fund profited illegally on Johnson & Johnson's ($JNJ) buyout of cancer drug developer Cougar Biotechnology in 2009. Article

> Sanford C. Bernstein analysts gave slim odds of a pharma company bidding on Abbott Labs' drug business amid Abbott's recent plans to split into two companies. Report

> Halozyme Therapeutics ($HALO) reported upbeat data from a Phase II trial of a fast-acting insulin formulation for diabetics. Release

> The FDA approved Watson Pharmaceuticals' ($WPI) its Androderm product, which is a patch that delivers testosterone through the skin. Item

> Merck ($MRK) said that its recently approved HepC drug Victrelis performed well in a clinical trial as a treatment for HIV. Report

Pharma News

@FiercePharma: Report: Abbott prescription med unit could bring $54M. News | Follow @FiercePharma

> EC investigates J&J, Novartis over generic Fentanyl delay. Story

> Schwan: Roche to pursue 'targeted acquisitions'. Article

> Merck to make new investments in Singapore. More

> AMAG stockholders vote against merger with Allos. Story

> Australian officials seek more info on Pfizer support program. Piece

> Actavis loses oxycodone, epilepsy meds in cargo theft. Report

And Finally... The British Medical Journal published research that provides more evidence that mobile phone use doesn't cause brain cancer. Article